Related Experiment Video
Updated: Sep 13, 2025
07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
23.3K
Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade After Approval
1Department of Urology, Charité-University Hospital, 12203 Berlin, Germany.
Toxins
|July 25, 2025
Summary
Botulinum toxin is FDA-approved for neurogenic bladder and overactive bladder (OAB). This treatment offers a new therapeutic option for patients with these challenging conditions.
Area of Science:
- Urology
- Pharmacology
Background:
- Botulinum toxin's efficacy for neurogenic bladder was established with FDA approval in 2011.
- Idiopathic overactive bladder (OAB) gained FDA approval for botulinum toxin treatment in 2013.
Discussion:
- Botulinum toxin injections represent a significant advancement in managing bladder dysfunction.
- The mechanism involves targeted muscle relaxation to improve bladder capacity and reduce incontinence episodes.
Key Insights:
- FDA approval validates botulinum toxin as a key therapeutic agent for specific bladder conditions.
- This highlights the growing role of neuromodulators in urological treatment paradigms.
Outlook:
- Further research may explore extended applications and optimal dosing strategies for botulinum toxin in urology.
- Investigating long-term outcomes and patient-reported benefits will be crucial for continued clinical adoption.
Related Concept Videos
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
889
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
889
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
835
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
835
01:26Cholinergic Antagonists: Therapeutic Uses
875
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
875
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
762
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
762
01:31Skeletal Muscle Relaxants: Therapeutic Uses
618
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
618
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
533
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
533